Prof. Lars Dyrskjøt is a professor at the Department of Clinical Medicine - Department of Molecular Medicine (MOMA), Aarhus University, Denmark.
His research group performs translational bladder cancer research with focus on:
- Identification and validation of biomarker models for predicting outcome and treatment response in early and late-stage bladder cancer (BCG, chemotherapy and immunotherapy)
- Liquid biopsy analysis and method development for monitoring early relapse and therapy response
- Understanding disease biology, tumor subtypes and tumor evolution